Markus J. Schwarz
Department of Neurochemistry
Psychiatric Hospital
University of Munich
Germany
[email]@psy.med.uni-muenchen.de
Name/email consistency: high
- Experimental evaluation of an altered tryptophan metabolism in fibromyalgia. Schwarz, M.J., Offenbaecher, M., Neumeister, A., Ackenheil, M. Adv. Exp. Med. Biol. (2003)
- The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Schwarz, M.J., Müller, N., Riedel, M., Ackenheil, M. Med. Hypotheses (2001)
- Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Schwarz, M.J., Späth, M., Müller-Bardorff, H., Pongratz, D.E., Bondy, B., Ackenheil, M. Neurosci. Lett. (1999)
- Antibodies to heat shock proteins in schizophrenic patients: implications for the mechanism of the disease. Schwarz, M.J., Riedel, M., Gruber, R., Ackenheil, M., Müller, N. Am. J. Psychiatry (1999)
- Melanoma-associated adhesion molecule MUC18/MCAM (CD146) and transcriptional regulator mader in normal human CNS. Schwarz, M.J., Müller, N., Körschenhausen, D., Kirsch, K.H., Penning, R., Ackenheil, M., Johnson, J.P., Hampel, H. Neuroimmunomodulation (1998)
- Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia. Schwarz, M.J., Ackenheil, M., Riedel, M., Müller, N. Neurosci. Lett. (1998)
